Abstract
Purpose
The purpose of this review is to shed light into the diagnostic challenges regarding idiopathic intracranial hypertension (IIH), giving more emphasis to the role of optical coherence tomography (OCT) in IIH, while it also presents recent advances in the management of IIH.
Methods
A literature search in PubMed was performed for studies about the diagnosis and management of IIH published before June 30, 2017. Then, a comprehensive review of the eligible studies and the relevant references was performed.
Results
Apart from the updated modified criteria, OCT has been found to be important for the diagnosis of IIH, along with assessment of clinical signs and symptoms, brain imaging, and lumbar puncture. On the other hand, there is no current consensus for the management of IIH, but various interventions have been used, such as dietary therapy (weight loss, bariatric surgery, lifestyle modification, low-salt diet), medications, and surgical treatment.
Conclusions
IIH is a challenging and serious disorder, which may lead to permanent visual impairment if there is a delay in its diagnosis. Advances in retinal imaging have led to better understanding of the pathogenesis of the disease and prompt diagnosis even in subtle cases can be done using OCT. Surgical interventions should be minimized and only used in cases refractory to medical treatment and in those with rapid progression.
Similar content being viewed by others
References
Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159–1165
Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18:1266–1268
Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991–1995). Ulster Med J 70:31–35
Kesler A, Stolovic N, Bluednikov Y, Shohat T (2014) The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol 21:1055–1059
Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 15:78–91
Donaldson JO (1979) Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc 104:196–198
Malm J, Kristensen B, Markgren P, Ekstedt J (1992) CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology 42:851–858
Johnston I (1973) Reduced CSF absorption syndrome: reappraisal of benign intracranial hypertension and related conditions. Lancet 2:418–421
Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 80:289–295
Hannerz J, Ericson K (2009) The relationship between idiopathic intracranial hypertension and obesity. Headache 49:178–184
Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 76:1564–1567
Samancı B, Samancı Y, Tüzün E, Altıokka-Uzun G, Ekizoğlu E, İçöz S, Şahin E, Küçükali CI, Baykan B (2017) Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. Cephalalgia 37:525–531
Dhungana S, Sharrack B, Woodroofe N (2009) Cytokines and chemokines in idiopathic intracranial hypertension. Headache 49:282–285
Killer HE, Jaggi GP, Miller NR (2011) Optic nerve compartment syndrome. Acta Ophthalmol 89:472
Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR, Mironov A (2007) Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional? Brain 130:514–520
Killer HE, Jaggi GP, Miller NR (2009) Papilledema revisited: is its pathophysiology really understood? Clin Exp Ophthalmol 37:444–447
Coker JG, Duker JS (1996) Macular disease and optical coherence tomography. Curr Opin Ophthalmol 7:33–38
Stanga PE, Bird AC (2001) Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol 23:191–197
Satue M, Obis J, Rodrigo MJ, Otin S, Fuertes MI, Vilades E, Gracia H, Ara JR, Alarcia R, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol 2016:8503859
Nolan RC, Narayana K, Galetta SL, Balcer LJ (2015) Optical coherence tomography for the neurologist. Semin Neurol 35:564–577
Costello F (2017) Optical coherence tomography in neuro-ophthalmology. Neurol Clin 35:153–163
Heidary G, Rizzo JF 3rd (2010) Use of optical coherence tomography to evaluate papilledema and pseudopapilledema. Semin Ophthalmol 25:198–205
Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495
Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808
Yri HM, Rönnbäck C, Wegener M, Hamann S, Jensen RH (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21:1458–1464
Amico D D, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G, Bianchi Marzoli S (2013) Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci 34(Suppl 1):S147–S149
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701
Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180
Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494
Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V (2015) Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol 35:31–36
Wall M, White WN 2nd (1998) Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 39:134–142
Frisén L (1982) Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 45:13–18
Sinclair AJ, Burdon MA, Nightingale PG, Matthews TD, Jacks A, Lawden M, Sivaguru A, Gaskin B, Rauz S, Clarke CE, Ball AK (2012) Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol 259:1406–1412
Thambisetty M, Lavin PJ, Newman NJ, Biousse V (2007) Fulminant idiopathic intracranial hypertension. Neurology 68:229–232
Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 7:26–29
Pollak L, Zohar E, Glovinsky Y, Huna-Baron R (2013) Reevaluation of presentation and course of idiopathic intracranial hypertension—a large cohort comprehensive study. Acta Neurol Scand 127:406–412
Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ (2014) A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 14:380–390
Cartlidge NE, Ng RC, Tilley PJ (1977) Dilemma of the swollen optic disc: a fluorescein retinal angiography study. Br J Ophthalmol 61:385–389
Bäuerle J, Nedelmann M (2011) Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension. J Neurol 258:2014–2019
Lam BL, Morais CG Jr, Pasol J (2008) Drusen of the optic disc. Curr Neurol Neurosci Rep 8:404–408
Scott CJ, Kardon RH, Lee AG, Frisén L, Wall M (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711
Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574
Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D'Amico D (2013) Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci 34(Suppl 1):S143–S145
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 55:8180–8188
Waisbourd M, Leibovitch I, Goldenberg D, Kesler A (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:839–843
Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP (2015) OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg 130:122–127
Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259:886–894
Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258:277–283
Wang JK, Kardon RH, Ledolter J, Sibony PA, Kupersmith MJ, Garvin MK, OCT Sub-Study Committee and the NORDIC Idiopathic Intracranial Hypertension Study Group (2017) Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the idiopathic intracranial hypertension treatment trial. Invest Ophthalmol Vis Sci 58:2554–2565
Chowdhury HR, Rajak S, Heath D, Brittain P (2015) Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration. BMJ Case Rep 2015. https://doi.org/10.1136/bcr-2014-204511
Kardon RH (2011) Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol 31:353–361
Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V (2015) Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 35:400–411
Chang RO, Marshall BK, Yahyavi N, Sharma A, Huecker J, Gordon MO, McClelland C, Van Stavern GP (2016) Neuroimaging features of idiopathic intracranial hypertension persist after resolution of papilloedema. Neuroophthalmology 40:165–170
Biousse V (2012) Idiopathic intracranial hypertension: diagnosis, monitoring and treatment. Rev Neurol (Paris) 168:673–683
Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP (2015) Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev CD003434. https://doi.org/10.1002/14651858.CD003434.pub3
Newborg B (1974) Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 133:802–807
Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094–1098
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701
Subramaniam S, Fletcher WA (2017) Obesity and weight loss in idiopathic intracranial hypertension: anarrative review. J Neuroophthalmol 37:197–205
Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D (2011) Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 114:34–39
Sugerman HJ, Felton WL 3rd, Salvant JB Jr, Sismanis A, Kellum JM (1995) Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 45:1655–1659
Levin AA, Hess D, Hohler AD (2015) Treatment of idiopathic intracranial hypertension with gastric bypass surgery. Int J Neurosci 125:78–80
Manfield JH, Yu KK, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg 27:513–521
Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258:874–881
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311:1641–1651
Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327
McCarthy KD, Reed DJ (1974) The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194–201
Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36:1899–1904
Starks V, Gilliland G, Vrcek I, Gilliland C (2016) Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness. Orbit 35:87–90
Obi EE, Lakhani BK, Burns J, Sampath R (2015) Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre. Clin Neurol Neurosurg 137:94–101
Pineles SL, Volpe NJ (2013) Long-term results of optic nerve sheath fenestration for idiopathic intracranial hypertension: earlier intervention favours improved outcomes. Neuroophthalmology 37:12–19
Tarrats L, Hernández G, Busquets JM, Portela JC, Serrano LA, González-Sepúlveda L, Sánchez-Pérez JR (2017) Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension. Int Forum Allergy Rhinol 7:615–623
Fonseca PL, Rigamonti D, Miller NR, Subramanian PS (2014) Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol 98:1360–1363
Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G (2011) Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31:1627–1633
Teleb MS, Cziep ME, Issa M, Lazzaro M, Asif K, Hong SH, Lynch JR, Fitzsimmons BF, Remler BF, Zaidat OO (2015) Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging 25:72–80
Teleb MS, Cziep ME, Lazzaro MA, Gheith A, Asif K, Remler B, Zaidat OO (2013) Idiopathic intracranial hypertension. A systematic analysis of transverse sinus stenting. Interv Neurol 2:132–143
De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 25:342–344
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Chatziralli, I., Theodossiadis, P., Theodossiadis, G. et al. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 256, 1217–1224 (2018). https://doi.org/10.1007/s00417-018-3970-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-018-3970-4